Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

What is the purpose of this trial?

Patients with partial seizures currently taking 1-3 antiepileptic medications will have a 50:50 chance to receive Lyrica 300 mg per day or placebo (no active ingredients) added on to their current medications for 3 months. Neither the study doctor nor the patient will know the medication assignment. Vision testing will be performed prior to receiving the study treatment and at the end of the study to see if there are any changes.


Participation Guidelines

Ages: 18 - 65 years

Gender: Both


Pfizer Inc., U.S. Pharmaceuticals Group

Start Date: 10/15/2015

End Date: 11/30/2019

Last Updated: 02/22/2018

Study HIC#: 1401013207

Get Involved

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image

Investigators

Hamada Hamid Altalib

Principal Investigator

Sub-Investigators